# Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia

> **NCT00637234** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Cologne** · enrollment: 54 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Oxcarbazepine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00637234
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2008-04
- **Final completion:** 2008-07
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2008-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00637234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00637234, "Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00637234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*